CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 from US$ 2.79 Billion in 2022
The global oncology industry is rapidly transforming with the adoption of advanced immunotherapy solutions, making the CAR-T Cell Therapy Market one of the fastest-growing sectors in cancer treatment. Chimeric antigen receptor T-cell therapies are revolutionizing the treatment landscape for hematologic malignancies by utilizing genetically modified T cells to target and destroy cancer cells....
0 Comments
0 Shares
25 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt